[ad_1] We’re adding to our lone oil stock and an out-of-favor medical-technology company. [ad_2] Source link
Continue readingTag: Abbott Laboratories
We're encouraged by an activist's willingness to buy an Abbott rival, look past baby formula suits
[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour […]
Continue reading
Abbott Labs' surprise guidance bump is a major positive for its shareholders
[ad_1] Abbott Laboratories delivered a top and bottom line beat Wednesday and surprised investors by raising its full-year guidance — a show of confidence by […]
Continue reading
We're buying more of this health-care company amid an overdone sell-off
[ad_1] Shortly after the opening bell, we will be buying 140 shares of Abbott Laboratories at roughly $112. Following the trade, Jim Cramer’s Charitable Trust […]
Continue reading
Nvidia stomps the bears. Plus, Cramer's thoughts on 2 struggling portfolio names
[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour […]
Continue reading
Jim Cramer: It's not too late to buy this portfolio health-care stock after Friday's selloff
[ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key […]
Continue reading